We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

NPLATE romiplostim (rbe) 230 microgram powder for injection vial (283890)

ARTG ID 283890

ARTG Name

NPLATE romiplostim (rbe) 230 microgram powder for injection vial

Product name

NPLATE romiplostim (rbe) 230 microgram powder for injection vial

ARTG Date

23 October 2017

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

Romiplostim

Licence category

RE

Licence status

A

Summary

Product Information

Related information

NPLATE romiplostim (rbe) 230 microgram powder for injection vial (2024-25)

2024-25

Annual charge exemption

Exempt from annual charge in 2024-25 due to Amgen Australia Pty Ltd declaring $0 turnover in that period.
NPLATE romiplostim (rbe) 625 microgram powder for injection vial, Amgen Australia Pty Ltd, CON-363

12 March 2019

Section 14 consent

Consent to Import and supply while noncompliant with standards. The consent is effective from 12 March 2019 until further notice.